announces

IBM Announces New Platform for Financial Institutions and Regulated Enterprises Entering the Digital Asset Economy

With IBM Digital Asset Haven, clients can manage digital assets across various blockchains, all while conforming to their sovereignty, security,…

3 months ago

Newmark Announces Expansion into India; Sathish Rajendren Hired to Lead Growth in Regional Property and Facilities Management

NEW YORK and BANGALORE, India, Oct. 27, 2025 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the Company"), a…

3 months ago

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

October 27, 2025 16:05 ET  | Source: Pulmonx Corporation Glen French, member of the Board of Directors and former Pulmonx…

3 months ago

Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares

MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced…

3 months ago

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

October 26, 2025 19:15 ET  | Source: Vivani Medical, Inc. ALAMEDA, Calif., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical,…

3 months ago

New Crypto Mutuum Finance (MUTM) Announces V1 Protocol as Investor Count Tops 17,400

Dubai, UAE, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Ethereum remains at the heart of decentralized finance (DeFi), powering hundreds of…

3 months ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

3 months ago

Prenetics Global Limited Announces Proposed Public Offering

October 24, 2025 20:30 ET  | Source: Prenetics Global Limited CHARLOTTE, N.C., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Prenetics Global…

3 months ago

PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

October 24, 2025 11:39 ET  | Source: PMV Pharmaceuticals, Inc. Data presented today as an oral presentation at 2025 AACR-NCI-EORTC…

3 months ago

IMG Announces 2025 Leave Your Mark Grant Winners

INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- IMG (International Medical Group) is excited to announce the winners of its ninth annual Leave Your…

3 months ago